Actin (Smooth Muscle) Antibodies (ASMA; anti-F-actin) are autoantibodies that target proteins in smooth muscle cells. They are most often linked to autoimmune hepatitis (AIH), especially type 1, but they can also appear in chronic active hepatitis and, less commonly, in primary biliary cholangitis (PBC, historically called “primary biliary cirrhosis”). Positivity is reported in about 52–85% of people with AIH or chronic active hepatitis and about 22% with PBC. ASMA often appears together with ANA (antinuclear antibodies) and high IgG levels, which form a typical autoimmune antibody pattern in AIH.
Why the test is done
-
Helps identify autoimmune hepatitis (AIH): If liver enzymes (ALT, AST) are high and other causes are ruled out, ASMA can point toward immune-related liver inflammation.
-
Helps distinguish liver conditions: Along with ANA, anti-LKM-1, anti-SLA, AMA, and total IgG, this test helps doctors tell AIH apart from PBC and other chronic liver diseases.
-
Strengthens the autoimmune suspicion: Higher levels increase the likelihood of an autoimmune cause, though the test is not diagnostic on its own.
How to interpret results
-
0–19 (Negative): Does not support autoimmune hepatitis by itself. If liver tests are abnormal, doctors will consider other causes (such as viral hepatitis, alcohol-related injury, metabolic disease, or medication effects) and may order other antibody or IgG tests.
-
20–30 (Weak positive): Borderline result suggesting possible autoimmune activity. Doctors interpret this together with liver enzyme patterns, other antibodies (ANA, AMA, anti-LKM-1, anti-SLA), IgG levels, liver-related symptoms (fatigue, itching, jaundice, joint pain), and imaging. Repeat testing or confirmation with an anti-F-actin ELISA test may sometimes be recommended.
-
Over 30 (Moderate to strong positive): Stronger evidence for AIH, particularly if IgG is elevated, ANA is also positive, and ALT/AST are high. Even then, diagnosis usually requires a combination of test results, scoring systems (such as IAIHG), and sometimes a liver biopsy to confirm characteristic inflammation and assess disease stage.
Important things to know
-
Specificity: ASMA is a useful piece of the diagnostic puzzle but not perfectly specific. It can also show up in PBC, viral hepatitis, or other autoimmune conditions.
-
Follow-up and monitoring: Antibody levels may fall with treatment, but changes in titers are not reliable for tracking disease activity. Doctors mainly monitor liver enzymes, bilirubin, IgG, symptoms, and may use imaging or biopsy.
-
Test methods differ: Some labs report ASMA qualitatively or as titers (such as 1:40, 1:80). These results correspond to the negative/weak/positive categories outlined above.
What happens next
-
If positive: Your doctor may suggest a full evaluation, including liver blood tests (ALT, AST, ALP, GGT, bilirubin), IgG, antibody panels (ANA, AMA, anti-LKM-1, anti-SLA), a viral hepatitis panel, and imaging (ultrasound or elastography). A liver biopsy may be considered to confirm and stage the disease.
-
If negative but suspicion remains: If liver enzymes stay high or autoimmune features continue, your doctor may still order other antibody tests, IgG, or imaging, and may repeat ASMA testing.
-
Treatment implications: If autoimmune hepatitis is confirmed, treatment usually involves immunosuppressive medication (often corticosteroids and sometimes azathioprine) to reduce liver inflammation and prevent progression to fibrosis or cirrhosis.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.